FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084499 [Registered on: 09/04/2025] Trial Registered Prospectively
Last Modified On: 08/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Using Artificial Intelligence to Help Detect Early and Recent Strokes on Brain Scans Without Contrast: A Study in Patients with Suspected Stroke 
Scientific Title of Study   AI-Powered Real-Time Detection and Quantitative Analysis of Bilateral acute and sub-acute Infarcts Using Non-Contrast Computed Tomography Imaging: A Deep Learning-Based Approach 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrAbdul Majith Seeni Mohammed 
Designation  Post Grduate 
Affiliation  Saveetha medical college and hospital, Saveetha institute of medical and technical sciences  
Address  Room no.50, Department of radiology, Saveetha medical college and hospital, Saveetha institute of medical and technical sciences,Saveetha nagar, Thandalam, Chennai, India

Kancheepuram
TAMIL NADU
602105
India 
Phone  8122336643  
Fax    
Email  drmajith2297@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrMuthiah Pitchandi 
Designation  Professor 
Affiliation  Saveetha medical college and hospital, Saveetha institute of medical and technical sciences  
Address  Room no.50, Department of radiology, Saveetha medical college and hospital, Saveetha institute of medical and technical sciences,Saveetha nagar, Thandalam, Chennai, India

Kancheepuram
TAMIL NADU
602105
India 
Phone  919843175404  
Fax    
Email  drmuthiahmd@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrMuthiah Pitchandi 
Designation  Professor 
Affiliation  Saveetha medical college and hospital, Saveetha institute of medical and technical sciences  
Address  Room no.50, Department of radiology, Saveetha medical college and hospital, Saveetha institute of medical and technical sciences,Saveetha nagar, Thandalam, Chennai, India

Kancheepuram
TAMIL NADU
602105
India 
Phone  919843175404  
Fax    
Email  drmuthiahmd@gmail.com  
 
Source of Monetary or Material Support  
Saveetha Medical College Hospital, Saveetha Nagar, Thandalam, Chennai-602105  
 
Primary Sponsor  
Name  Dr.Abdul Majith Seeni Mohammed 
Address  Saveetha Medical College Hospital, Saveetha Nagar, Thandalam, Chennai-602105 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrAbdul Majith Seeni Mohammed  Saveetha Medical College Hospital  Room no 50, Department of Radiology, Saveetha Medical College Hospital, Saveetha Nagar, Thandalam, Chennai. Chennai TAMIL NADU
Kancheepuram
TAMIL NADU 
8122336643

drmajith2297@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
No of Ethics Committees= 1 Name of Committee Ethics Committee registered with DHR /CDSCO or not Ethics Committee Registration No. Approval Status Date of Approval Approval Document Is IEC? Saveetha Medical College and Hospital Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G988||Other disorders of nervous system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1)Patients aged 18 years and above.
2)Presenting with acute or subacute neurological symptoms suggestive of stroke (e.g., weakness, slurred speech, visual disturbances, altered sensorium).
3)Undergoing non-contrast CT (NCCT) of the brain as part of initial evaluation.
4)Undergoing MRI with diffusion-weighted imaging (DWI) within 72 hours of the NCCT for diagnostic correlation.
5)Symptom onset within 1 to 72 hours prior to imaging.
6)Informed consent obtained from the patient or legally authorized representative 
 
ExclusionCriteria 
Details  1)Poor-quality NCCT images due to motion artifacts or technical issues.
2)Presence of non-ischemic pathology on CT such as hemorrhage, tumors, trauma, or postoperative changes.
3)History of prior stroke in the same vascular territory.
4)Inability to undergo MRI, including contraindications such as pacemakers, metallic implants, severe claustrophobia, or clinical instability.
5)Patients who have received reperfusion therapy (e.g., thrombolysis or thrombectomy) before the baseline NCCT.
6)Incomplete clinical, laboratory, or follow-up imaging data that prevents accurate analysis.

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Diagnostic accuracy of AI in detecting bilateral MCA infarcts on non-contrast CT, measured by sensitivity, specificity, PPV, NPV, and AUC-ROC.  Real-time analysis immediately after CT scan 
 
Secondary Outcome  
Outcome  TimePoints 
1)Diagnostic accuracy of AI in detecting infarcts across ASPECTS severity categories (0–4, 5–7, 8–10), measured by sensitivity.
2)Time-to-diagnosis comparison between AI & radiologists, measured in minutes from CT scan completion to diagnosis report generation.
3)Clinical impact of AI on decision-making, measured by the proportion of cases with expedited thrombolysis, avoided MRI, & discordant reads requiring MRI confirmation. 
1)Within 1 hour of AI analysis.
2)mmediately after CT scan completion.
3)Within 24–48 hours post-imaging. 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   19/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study aims to evaluate the diagnostic accuracy of an AI-driven real-time detection system for acute and sub-acute infarcts using non-contrast CT images. The study will assess the sensitivity, specificity, and clinical utility of AI-based infarct detection compared to expert radiologist interpretation. By leveraging deep learning algorithms, the system provides automated infarct detection, real-time image analysis, and AI-generated reports, assisting in early stroke diagnosis and management. The study will be conducted as a prospective observational diagnostic accuracy study, comparing AI results with the gold standard (radiologist reports and follow-up MRI-DWI findings). The findings will help determine the effectiveness and reliability of AI in infarct detection, particularly in resource-limited settings where radiology expertise may be scarce. 
Close